# A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors

Source: https://onco.cc/trials/nct06581419/  
OnCo record `nct06581419` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of IAP0971 in non-small-cell lung cancer, run by SUNHO（China）BioPharmaceutical CO., Ltd., now recruiting.

## Summary

A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors is a phase 1/2 interventional study registered as NCT06581419 by SUNHO（China）BioPharmaceutical CO., Ltd., with 78 participants planned, started 2024-12-31 and due to reach its primary completion in 2029-08-01. Interventions recorded: IAP0971.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06581419
- Phase: 1/2
- Setting: A Phase I/II Clinical Study Evaluating Safety, Tolerability, and Efficacy of IAP0971 in Advanced Tumors
- Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd.
- Enrolled: 78

## Sources

- ClinicalTrials.gov NCT06581419: https://clinicaltrials.gov/study/NCT06581419

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)

---
JSON: https://onco.cc/api/v1/entities/nct06581419.json